BioSpace News Archive

Arvinas, Inc. announced that nearly 200 employees participated in the Company’s inaugural “Arvinas Impact Day,” a company-wide community service day benefiting organizations in the Greater New Haven area.

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM).

Valneva SE announced the pricing of 21,000,000 ordinary shares in a global offering to specified categories of investors comprised of a public offering of 375,000 American Depositary Shares, each representing two ordinary shares, in the United States and a concurrent private placement of 20,250,000 ordinary shares in certain jurisdictions outside of the United States.

As per 30 September 2022, the total number of shares in Swedish Orphan Biovitrum AB amounts to 309,804,782 shares.

scPharmaceuticals Inc. today announced two poster presentations, including a late breaker, at the Heart Failure Society of America (HFSA) 2022 Annual Meeting, which is being held September 30 – October 3, in Washington DC.

Edesa Biotech, Inc. announced final results from the Phase 2 portion of its ongoing Phase 2/Phase 3 clinical study.

ALR Technologies Inc., the diabetes management company, is pleased to announce an update with respect to its migration to Singapore.

Forza Innovations Inc. today announced the completion of a new tranche of funding, totaling $250,000.

OpGen, Inc. today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale in a registered direct offering of 9,660,000 shares of the Company’s common stock (or common stock equivalents), 33,810 shares.

Kibow Biotech, Inc., a clinical-stage biotechnology company developing live biotherapeutics that target the dysbiosis in patients with CKD, celebrated a 25-year legacy of dedication to improving the lives of patients with kidney disease.